small molecule

LUPRON DEPOT

LEUPROLIDE ACETATE

Loss of exclusivityloss of exclusivity
CompanyABBVIE ENDOCRINE INC

Drug detail

Brand nameLUPRON DEPOT
Active ingredientLEUPROLIDE ACETATE
Strength3.75MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalOctober 1990
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

LUPRON DEPOT patent cliff — loss of exclusivity — | CliffBio